Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Positron emission tomography molecular imaging in late-life depression.

Hirao K, Smith GS.

J Geriatr Psychiatry Neurol. 2014 Mar;27(1):13-23. doi: 10.1177/0891988713516540. Epub 2014 Jan 5. Review.

PMID:
24394152
2.

Molecular imaging of the serotonin 5-HT7 receptors: from autoradiography to positron emission tomography.

Zimmer L, Billard T.

Rev Neurosci. 2014;25(3):357-65. doi: 10.1515/revneuro-2014-0003. Review.

PMID:
24497222
3.

Molecular imaging of neuropsychiatric symptoms in Alzheimer's and Parkinson's disease.

Hirao K, Pontone GM, Smith GS.

Neurosci Biobehav Rev. 2015 Feb;49:157-70. doi: 10.1016/j.neubiorev.2014.11.010. Epub 2014 Nov 20. Review.

4.

PET tracers for serotonin receptors and their applications.

Kumar JS, Mann JJ.

Cent Nerv Syst Agents Med Chem. 2014;14(2):96-112. Review.

5.

Comparison of 4 radiolabeled antagonists for serotonin 5-HT(7) receptor neuroimaging: toward the first PET radiotracer.

Lemoine L, Andries J, Le Bars D, Billard T, Zimmer L.

J Nucl Med. 2011 Nov;52(11):1811-8. doi: 10.2967/jnumed.111.089185. Epub 2011 Oct 11.

6.

Linking variability in brain chemistry and circuit function through multimodal human neuroimaging.

Fisher PM, Hariri AR.

Genes Brain Behav. 2012 Aug;11(6):633-42. doi: 10.1111/j.1601-183X.2012.00786.x. Epub 2012 Apr 18. Review.

7.

Imaging dopamine neurotransmission in live human brain.

Badgaiyan RD.

Prog Brain Res. 2014;211:165-82. doi: 10.1016/B978-0-444-63425-2.00007-6.

8.

Molecular brain imaging in the multimodality era.

Price JC.

J Cereb Blood Flow Metab. 2012 Jul;32(7):1377-92. doi: 10.1038/jcbfm.2012.29. Epub 2012 Mar 21. Review.

9.

Brain network dysfunction in late-life depression: a literature review.

Tadayonnejad R, Ajilore O.

J Geriatr Psychiatry Neurol. 2014 Mar;27(1):5-12. doi: 10.1177/0891988713516539. Epub 2013 Dec 30. Review.

PMID:
24381233
10.

Pictorial review of in vivo human brain: from anatomy to molecular imaging.

Cho ZH, Kang CK, Son YD, Choi SH, Lee YB, Paek SH, Park CW, Chi JG, Calamante F, Law M, Kim YB.

World Neurosurg. 2014 Jul-Aug;82(1-2):72-95. doi: 10.1016/j.wneu.2012.10.020. Epub 2012 Oct 24. Review.

PMID:
23103260
11.

Development of radioligands for the imaging of α7 nicotinic acetylcholine receptors with positron emission tomography.

Brust P, Peters D, Deuther-Conrad W.

Curr Drug Targets. 2012 May;13(5):594-601. Review.

PMID:
22300025
12.

PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.

Billard T, Le Bars D, Zimmer L.

Curr Med Chem. 2014;21(1):70-81. Review.

PMID:
23992341
13.

Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging.

Colomb J, Becker G, Forcellini E, Meyer S, Buisson L, Zimmer L, Billard T.

Nucl Med Biol. 2014 Apr;41(4):330-7. doi: 10.1016/j.nucmedbio.2014.01.008. Epub 2014 Jan 17.

PMID:
24607435
14.

Neuroimaging in late-life depression.

Vaishnavi S, Taylor WD.

Int Rev Psychiatry. 2006 Oct;18(5):443-51. Review.

PMID:
17085363
15.

PET and SPET molecular imaging: focus on serotonin system.

Moresco RM, Matarrese M, Fazio F.

Curr Top Med Chem. 2006;6(18):2027-34. Review.

PMID:
17017972
16.

Serotonin-1A receptor imaging in recurrent depression: replication and literature review.

Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, Mathis C.

Nucl Med Biol. 2007 Oct;34(7):865-77. Review.

17.

Neurochemical imaging in schizophrenia.

Urban N, Abi-Dargham A.

Curr Top Behav Neurosci. 2010;4:215-42. Review.

PMID:
21312402
18.

Molecular neuroimaging: from conventional to emerging techniques.

Hammoud DA, Hoffman JM, Pomper MG.

Radiology. 2007 Oct;245(1):21-42. Review.

PMID:
17885179
19.

An overview of PET neuroimaging.

Nasrallah I, Dubroff J.

Semin Nucl Med. 2013 Nov;43(6):449-61. doi: 10.1053/j.semnuclmed.2013.06.003. Review.

PMID:
24094712
20.

Supplemental Content

Support Center